IP Library Granted Patent US 10,280,196
Granted Patent B2
US 10,280,196 · App. 15/112,984 · Granted May 7, 2019

Heparin affinity tag and application thereof

Inventors: Suresh Kumar Thallapuranam (Fayetteville, AR); Srinivas Jayanthi (Fayetteville, AR); Jacqueline Morris (Fayetteville, AR); Alicia Brown (Springdale, AR); David McNabb (Fayetteville, AR); Ralph Henry (Fayetteville, AR)
Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
C07K1/22B01D15/206B01D15/22B01D15/3809B01D69/08B01J20/286B01J20/28078C07K14/00C12N9/6424C12Y304/21043C07K2319/20C07K2319/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,280,196
App. No.
15/112,984
Granted
May 7, 2019
Kind
B2
Abstract

In one aspect, affinity tags for recombinant protein purification are described herein which, in some embodiments, can mitigate or overcome disadvantages of prior affinity tag systems. In some embodiments, for example, affinity tags described herein permit efficient elution of desired recombinant proteins with simplified solution systems, such as alkali metal salt solutions. An affinity tag described herein comprises an amino acid sequence including a repeating amino acid unit of BXXXBXX, wherein B is an amino acid selected from the group consisting of histidine, lysine and arginine and X is an amino acid selected from the group consisting of amino acids other than histidine, lysine and arginine.

Claims (19)

1. A separation medium comprising:

a membrane support phase; and

a stationary phase attached to the support phase, the stationary phase including an amino acid sequence comprising the sequence of SEQ ID NO: 1 or SEQ ID NO: 2.

2. The separation medium of claim 1 , wherein the amino acid sequence is attached to the support phase through a spacer.

3. The separation medium of claim 2 , wherein the spacer comprises a hydrocarbon section.

4. The separation medium of claim 3 , wherein the hydrocarbon section comprises a C 4 to C 20 hydrocarbon.

5. The separation medium of claim 1 , wherein the membrane support phase is porous.

6. The separation medium of claim 5 , wherein the membrane support phase has an average pore size less than 200 μm.

7. The separation medium of claim 1 , wherein the membrane support phase is non-porous.

8. The separation medium of claim 1 , wherein the membrane support phase comprises a polymeric material.

9. The separation medium of claim 8 , wherein the polymeric material is a synthetic polymer.

10. The separation medium of claim 9 , wherein the synthetic polymer is selected from the group consisting of polyolefin, polyesters, polyamides, polystyrene, polycarbonates, polyurethanes or copolymers thereof.

11. The separation medium of claim 8 , wherein the polymeric material is a natural polymer.

12. The separation medium of claim 11 , wherein the natural polymer is cellulose or cellulosic derivative.

13. A method of removing heparin from a biological fluid comprising:

contacting the biological fluid with a separation medium comprising a support phase and a stationary phase attached to the support phase, the stationary phase including an amino acid sequence comprising the sequence of SEQ ID NO: 1 or SEQ ID NO: 2; and

binding heparin in the biological fluid to the stationary phase.

14. The method of claim 13 , wherein the amino acid sequence is attached to the support phase through a spacer.

15. The method of claim 13 , wherein the biological fluid is selected from the group consisting of blood, plasma, serum, interstitial, amniotic, cerebrospinal, pericardial, peritoneal and pleural fluids.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: THALLAPURANAM, SURESH KUMAR; JAYANTHI, SRINIVAS; MORRIS, JACQUELINE; BROWN, ALICIA; MCNABB, DAVID; HENRY, RALPH
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 046639/0050 →
CONFIRMATORY LICENSE Recorded Aug 9, 2016
From: UNIVERSITY OF ARKANSAS AT FAYETTEVILLE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039631/0782 →
Continuity (2)
Continuation In Part PCTUS2014012340 · Jan 21, 2014
Related Publication 20170029461A1 · Feb 2, 2017